KnowTheStock
Log inCreate free account

Lilly(Eli) & Co

LLY
S&P 500Pharmaceutical Preparation Manufacturing · NEW YORK STOCK EXCHANGE INC.
$1.00last close · market cap 893.70 Million
Compare with…
76.2SCORE / 100
Our verdictHOLDStrong Growth and ImprovingQtr Ending 2026-06-30 · trend positive

Why Hold

Income statement and cash flow are strong; balance sheet is moderate.

Next earnings: 2026-10-29 (BMO), EPS Forecast: $5.38

What is strong
  • Revenue Growth is 49.58%
  • Operating Income Growth is 76.51%
  • Net Income Growth is 93.56%
  • Earnings Per Share (EPS) Growth is 94.9%
  • Net Margin is 33.53%
  • Total Debt to Total Assets Ratio is 0.39
  • Cash from Operations Growth is 156.73%
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Current Asset to Current Liability Ratio is 1.35
  • Debt Ratio is 0.76
  • Current Debt to Net Income Ratio is 0.99
  • Investment Risk is High

What changed

Score by quarter

Upgraded from Sell to Hold in the Jun 2024 quarter: 64.5 → 65.5 (+1.0). This quarter: +0.0.

50607080Sep 2022Jun 2026

What the score is made of

Income statement89.2 +0.1
Balance sheet52.7 -0.1
Cash flow74.4 +0.0

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)79.67 Billion49.58 % growth
EPS29.8094.90 % growth
Profit margin33.53 %Profit per $1 of sales
P-E ratio—Not available
Market cap893.70 MillionShares × price
Debt-equity ratio1.62Leverage
Dividend6.46Per share, annual
Next earnings2026-10-29BMO · EPS forecast $5.38
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Lilly(Eli) & Co

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

CEO
David Ricks
Employees
2,020
Sector
Manufacturing
Exchange
NEW YORK STOCK EXCHANGE INC.
www.lilly.com

Similar stocks

Loading…